Improving the developability profile of pyrrolidine progesterone receptor partial agonists.
Kallander, L.S., Washburn, D.G., Hoang, T.H., Frazee, J.S., Stoy, P., Johnson, L., Lu, Q., Hammond, M., Barton, L.S., Patterson, J.R., Azzarano, L.M., Nagilla, R., Madauss, K.P., Williams, S.P., Stewart, E.L., Duraiswami, C., Grygielko, E.T., Xu, X., Laping, N.J., Bray, J.D., Thompson, S.K.(2010) Bioorg.Med.Chem.Lett. 20: 371-374
- PubMed: 19926282 
- DOI: 10.1016/j.bmcl.2009.10.092
- PubMed Abstract: 
The previously reported pyrrolidine class of progesterone receptor partial agonists demonstrated excellent potency but suffered from serious liabilities including hERG blockade and high volume of distribution in the rat. The basic pyrrolidine amine w ...